{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T15:36:26Z","timestamp":1775230586059,"version":"3.50.1"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1097\/mop.0000000000000238","type":"journal-article","created":{"date-parts":[[2015,6,18]],"date-time":"2015-06-18T12:49:51Z","timestamp":1434631791000},"page":"454-459","source":"Crossref","is-referenced-by-count":7,"title":["Beta-blockers for childhood vascular tumors"],"prefix":"10.1097","volume":"27","author":[{"given":"Cheryl B.","family":"Bayart","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heather A.","family":"Brandling-Bennett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-9-20210206","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1542\/peds.2006-0413","article-title":"Prospective study of infantile hemangiomas: clinical characteristics predicting complications and treatment.","volume":"118","author":"Haggstrom","year":"2006","journal-title":"Pediatrics"},{"key":"R2-9-20210206","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1056\/NEJMc0708819","article-title":"Propranolol for severe hemangiomas of infancy.","volume":"358","author":"Leaute-Labreze","year":"2008","journal-title":"N Engl J Med"},{"key":"R3-9-20210206","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1542\/peds.2012-1691","article-title":"Initiation and use of propranolol for infantile hemangioma: report of a consensus conference.","volume":"131","author":"Drolet","year":"2013","journal-title":"Pediatrics"},{"key":"R4-9-20210206","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/pde.12089","article-title":"Propranolol and infantile hemangiomas four years later: a systematic review.","volume":"30","author":"Marqueling","year":"2013","journal-title":"Pediatr Dermatol"},{"key":"R5-9-20210206","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1097\/PRS.0b013e31827c6fab","article-title":"Propranolol versus corticosteroids in the treatment of infantile hemangioma: a systematic review and meta-analysis.","volume":"131","author":"Izadpanah","year":"2013","journal-title":"Plast Reconstr Surg"},{"key":"R6-9-20210206","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1056\/NEJMoa1404710","article-title":"A randomized, controlled trial of oral propranolol in infantile hemangioma.","volume":"372","author":"Leaute-Labreze","year":"2015","journal-title":"N Engl J Med"},{"key":"R7-9-20210206","doi-asserted-by":"crossref","first-page":"e314","DOI":"10.1542\/peds.2011-3683","article-title":"Early growth of infantile hemangiomas: what parents photographs tell us.","volume":"130","author":"Tollefson","year":"2012","journal-title":"Pediatrics"},{"key":"R8-9-20210206","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.jaad.2014.12.019","article-title":"Is cardiovascular evaluation necessary prior to and during beta-blocker therapy for infantile hemangiomas A cohort study.","volume":"72","author":"Raphael","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"R10-9-20210206","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/bjd.13388","article-title":"The use of propranolol in the treatment of infantile haemangiomas: an update on potential mechanisms of action.","volume":"172","author":"Ji","year":"2015","journal-title":"Br J Dermatol"},{"key":"R11-9-20210206","doi-asserted-by":"crossref","first-page":"S119","DOI":"10.1097\/SAP.0000000000000272","article-title":"Propranolol promotes accelerated and dysregulated adipogenesis in hemangioma stem cells.","volume":"73","author":"England","year":"2014","journal-title":"Ann Plast Surg"},{"key":"R12-9-20210206","first-page":"3809","article-title":"Propranolol enhanced adipogenesis instead of induction of apoptosis of hemangiomas stem cells.","volume":"7","author":"Ma","year":"2014","journal-title":"Int J Clin Exp Pathol"},{"key":"R13-9-20210206","first-page":"48","article-title":"Propranolol inhibits angiogenesis via down-regulating the expression of vascular endothelial growth factor in hemangioma derived stem cell.","volume":"7","author":"Zhang","year":"2013","journal-title":"Int J Clin Exp Pathol"},{"key":"R14-9-20210206","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3389\/fsurg.2014.00038","article-title":"Biology of infantile hemangioma.","volume":"1","author":"Itinteang","year":"2014","journal-title":"Front Surg"},{"key":"R15-9-20210206","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1016\/j.bjps.2013.07.035","article-title":"Treatment of infantile haemangiomas with atenolol: comparison with a historical propranolol group.","volume":"66","author":"de Graaf","year":"2013","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"R16-9-20210206","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.jaad.2014.01.905","article-title":"Atenolol versus propranolol for the treatment of infantile hemangiomas: a randomized controlled study.","volume":"70","author":"Abarzua-Araya","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"R17-9-20210206","doi-asserted-by":"crossref","first-page":"44","DOI":"10.2146\/ajhp140097","article-title":"Nadolol for the treatment of infantile hemangioma.","volume":"72","author":"Villalba-Moreno","year":"2015","journal-title":"Am J Health Syst Pharm"},{"key":"R18-9-20210206","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1365-2230.2012.04425.x","article-title":"Topical timolol maleate for treatment of infantile haemangiomas: preliminary results of a prospective study.","volume":"38","author":"Semkova","year":"2013","journal-title":"Clin Exp Dermatol"},{"key":"R19-9-20210206","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1525-1470.2011.01664.x","article-title":"Timolol maleate 0.5 or 0.1 gel-forming solution for infantile hemangiomas: a retrospective, multicenter, cohort study.","volume":"29","author":"Chakkittakandiyil","year":"2012","journal-title":"Pediatr Dermatol"},{"key":"R20-9-20210206","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1525-1470.2012.01723.x","article-title":"Topical timolol for small hemangiomas of infancy.","volume":"30","author":"Moehrle","year":"2013","journal-title":"Pediatr Dermatol"},{"key":"R21-9-20210206","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1111\/ced.12150","article-title":"Imiquimod 5 cream versus timolol 0.5 ophthalmic solution for treating superficial proliferating infantile haemangiomas: a retrospective study.","volume":"38","author":"Qiu","year":"2013","journal-title":"Clin Exp Dermatol"},{"key":"R22-9-20210206","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1097\/SAP.0000000000000390","article-title":"Local administration of -blockers for infantile hemangiomas: a systematic review and meta-analysis.","volume":"74","author":"Ovadia","year":"2015","journal-title":"Ann Plast Surg"},{"key":"R23-9-20210206","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s12519-014-0509-6","article-title":"Topical treatment with propranolol gel as a supplement to the existing treatment of hemangiomas.","volume":"10","author":"Schneider","year":"2014","journal-title":"World J Pediatr"},{"key":"R24-9-20210206","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1111\/pde.12420","article-title":"Ulcerated infantile hemangioma: novel treatment with topical brimonidine-timolol.","volume":"31","author":"Beal","year":"2014","journal-title":"Pediatr Dermatol"},{"key":"R26-9-20210206","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/pde.12299","article-title":"Fractional carbon dioxide laser-assisted drug delivery of topical timolol solution for the treatment of deep infantile hemangioma: a pilot study.","volume":"31","author":"Ma","year":"2014","journal-title":"Pediatr Dermatol"},{"key":"R27-9-20210206","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1684\/ejd.2013.2146","article-title":"Propranolol and infantile hemangiomas: different routes of administration, a randomized clinical trial.","volume":"23","author":"Zaher","year":"2013","journal-title":"Eur J Dermatol"},{"key":"R28-9-20210206","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/pde.12217","article-title":"Treatment of pediatric pyogenic granulomas using -adrenergic receptor antagonists.","volume":"31","author":"Wine Lee","year":"2014","journal-title":"Pediatr Dermatol"},{"key":"R29-9-20210206","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1097\/MPH.0b013e318298ae9e","article-title":"Medical management of tumors associated with Kasabach-Merritt phenomenon: an expert survey.","volume":"35","author":"Tlougan","year":"2013","journal-title":"J Pediatr Hematol Oncol"},{"key":"R30-9-20210206","doi-asserted-by":"crossref","first-page":"e171","DOI":"10.1097\/MPH.0b013e3182152e4e","article-title":"Kaposiform hemangioendothelioma with Kasabach-Merritt syndrome: a new indication for propranolol treatment.","volume":"33","author":"Hermans","year":"2011","journal-title":"J Pediatr Hematol Oncol"},{"key":"R32-9-20210206","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1002\/pbc.24103","article-title":"Variable response to propranolol treatment of kaposiform hemangioendothelioma, tufted angioma, and Kasabach-Merritt phenomenon.","volume":"59","author":"Chiu","year":"2012","journal-title":"Pediatr Blood Cancer"}],"container-title":["Current Opinion in Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MOP.0000000000000238","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T03:29:49Z","timestamp":1620962989000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00008480-201508000-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/mop.0000000000000238","relation":{},"ISSN":["1040-8703"],"issn-type":[{"value":"1040-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]}}}